Axio provides complete support for Data Monitoring Committees (DMC). DMCs, independent panels of experts, are recommended by the FDA for many later stage clinical trials, particularly for those presenting significant risk to the patient. Using advanced statistical methodologies and state-of-the-art tools, Axio biostatisticians can assist in developing interim analysis designs customized to your goals and objectives. Axio is one of a few centers of excellence in this field. Axio’s services include:

• Assisting in identifying members;
• Drafting charters and interim analysis plans;
• Designing and programming statistical reports and analyses for the DMC;
• Coordinating meeting arrangements;
• Producing and presenting Open and Closed DMC Reports;
• Drafting minutes;
• Providing any necessary follow-up analyses and support to the DMC; and
• Representing, to the DMC, a source knowledgeable about the study data and its conduct.